MRP Millrose Properties, Inc.
Millrose Properties, Inc. is the premier permanent capital solution for residential homebuilders and developers. The company specializes in the acquisition, financing and development of residential land through long-term, capital-efficient structures. The company also provides homebuilders with a predictable, just-in-time supply of finished homesites the scarcest and mission-critical resource in the homebuilding industry. Millrose utilizes a proprietary technology platform that provides real-time feedback and data analytics to drive acquisition decisions. Every transaction in the Millrose portfolio undergoes rigorous independent due diligence to ensure attractive yields and long-term viability. By enabling an asset-light model, Millrose provides its diverse roster of homebuilder partners with the strategic flexibility to maintain production volumes and optimize balance sheet efficiency across all market environments. Millrose Properties, Inc.is based in Miami, United States.…
Industry Peers
REIT - ResidentialKey Statistics
About Millrose Properties (NYSE: MRP)
›
Millrose Properties (NYSE: MRP) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the REIT - Residential industry, part of the Real Estate sector.
The shares were at 24.84 USD on 19 November 2026, down 11.8% over 52 weeks. Its 52-week range is 21.08 USD to 32.60 USD: the price is 23.8% below the high and 17.8% above the low.
At a market capitalisation of 4.12B USD, it trades at 8.2 times trailing earnings and 7.5 times forward earnings. The median trailing P/E of its 15 largest REIT - Residential peers is 30.0, a discount of 73% for MRP. It pays a dividend yielding 12.60% (it pays out 102% of its earnings), against a median of 4.38% among the dividend payers in that peer group.
Millrose Properties reports return on equity of 6.5%, an operating margin of 85.2% and revenue up 17.7% year over year.
Its debt exceeds its cash by 3.29B USD, a debt-to-equity ratio of 0.36. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 5 analysts cover the stock; their mean price target of 36.00 USD is 44.9% above the current price. The next earnings report is expected on 25 February 2027.